Boltz offers the Boltz Lab platform, including the BoltzMol-1 and BoltzProt-1 models, so scientists at pharmaceutical, biotech and industrial companies can design molecules. Boltz started in 2025.
Boltz: Venture Capital Funding History
Boltz
Boltz
- Life Sciences
- London, United Kingdom
- £85m
- boltz.com
- Update Information
More venture news
- 18 Nov 2026

BoltzBoltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design
Series ALife Sciences - 13 Nov 2026

Oyster TherapeuticsOyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
Series ALife Sciences - 10 Nov 2026

Neobe TherapeuticsNeobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
SeedLife Sciences
